Lixte Biotechnology Holdings Stock Price on June 2, 2021

LIXT Stock  USD 3.52  1.26  55.75%   
Below is the normalized historical share price chart for Lixte Biotechnology Holdings extending back to September 21, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lixte Biotechnology stands at 3.52, as last reported on the 28th of March, with the highest price reaching 4.40 and the lowest price hitting 3.05 during the day.
IPO Date
21st of September 2007
200 Day MA
2.8755
50 Day MA
2.2948
Beta
(0.32)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Lixte Stock, it is important to understand the factors that can impact its price. Lixte Biotechnology is dangerous given 3 months investment horizon. Lixte Biotechnology has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.04% are justified by taking the suggested risk. Use Lixte Biotechnology Downside Deviation of 5.03, mean deviation of 5.04, and Risk Adjusted Performance of 0.0727 to evaluate company specific risk that cannot be diversified away.
  
At this time, Lixte Biotechnology's Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 51.4 M in 2024, whereas Common Stock is likely to drop 213.75 in 2024. . At this time, Lixte Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.03 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.10) in 2024. Lixte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1088

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsLIXT
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 9.59
  actual daily
84
84% of assets are less volatile

Expected Return

 1.04
  actual daily
20
80% of assets have higher returns

Risk-Adjusted Return

 0.11
  actual daily
8
92% of assets perform better
Based on monthly moving average Lixte Biotechnology is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lixte Biotechnology by adding it to a well-diversified portfolio.
Price Book
10.2517
Book Value
0.22
Enterprise Value
4.4 M
Enterprise Value Ebitda
(0.86)
Shares Float
M

Lixte Biotechnology Valuation on June 2, 2021

It is possible to determine the worth of Lixte Biotechnology on a given historical date. On June 2, 2021 Lixte was worth 1.31 at the beginning of the trading date compared to the closed value of 11.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lixte Biotechnology stock. Still, in general, we apply an absolute valuation method to find Lixte Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lixte Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lixte Biotechnology's related companies.
 Open High Low Close Volume
03/14/2022
  1.31    11.70    11.70    11.70    3,856  
  1.13    11.00    11.00    11.00    1,961  
Backtest Lixte Biotechnology  |  Lixte Biotechnology History  |  Lixte Biotechnology Valuation Next  
Open Value
1.31
11.7
Closing Value
30.08
Upside

Lixte Biotechnology Trading Date Momentum on June 2, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Lixte Biotechnology Fundamentals Correlations and Trends

By evaluating Lixte Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lixte Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lixte financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Lixte Biotechnology Stock history

Lixte Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lixte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lixte Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lixte Biotechnology stock prices may prove useful in developing a viable investing in Lixte Biotechnology
Last ReportedProjected for 2024
Common Stock Shares Outstanding1.9 M1.8 M
Net Loss-6.1 M-5.8 M

Lixte Biotechnology Quarterly Net Working Capital

3.99 Million

Lixte Biotechnology Stock Technical Analysis

Lixte Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lixte Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lixte Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Lixte Biotechnology Period Price Range

Low
March 14, 2022
High

 1.31 

  

 11.70 

10.39793.13%

Lixte Biotechnology March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on investment. By undertsting and applying Lixte Biotechnology stock market strength indicators, traders can identify Lixte Biotechnology Holdings entry and exit signals to maximize returns

Lixte Biotechnology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Lixte Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Lixte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lixte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Lixte Biotechnology is a strong investment it is important to analyze Lixte Biotechnology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lixte Biotechnology's future performance. For an informed investment choice regarding Lixte Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Lixte Stock analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Lixte Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lixte Biotechnology. If investors know Lixte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lixte Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.66)
Return On Assets
(0.64)
Return On Equity
(1.11)
The market value of Lixte Biotechnology is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotechnology's market value can be influenced by many factors that don't directly affect Lixte Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lixte Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.